The risk may very well be a lot less with bromocriptine. agonists used for hyperprolactinemia have not shown an elevated danger of valvular heart problems, but the chance should be mentioned with individuals, and echocardiographic surveillance needs to be regarded, particularly when doses > three mg a week are utilised. The danger could be signific